Serum Institute Developing Vaccine To Protect From JN.1 Variant: Former ICMR DG

Hyderabad, Dec 28 (Maxim News):  Allaying fears among people following the surge of covid infections due to JN.1 the new sub-variant of the coronavirus, former Director General of indian Council of Medical Research (ICMR), Dr. Balram Bhargava said that initial signs of the recent rise of covid cases clearly indicate mild infections.  

Dr. Bhargava, who played a central role in the country’s response during the three-waves of Covid pandemic, said the Serum Institute was developing a vaccine that has the potential to provide protection even from the recently identified JN.1 sub-variant. 

“Apparently, Serum Institute has a vaccine based on nanotechnology, which has been exported to the United States.  While it is still early days, this vaccine has a lot of promise and appears to be effective against the JN.1, he said. (Maxim News) 

Next Story :

Now you can get the latest stories from Indtoday on Telegram every day. Click the link to subscribe.  Click to follow Indtoday’s Facebook page, Twitter and Instagram. For all the latest Hyderabad News updates